European attitudes to gene therapy and pharmacogenetics
Authors:
- John HudsonJHJohn Hudson
- Marta OrviskaMOMarta Orviska
- 1 October 2011
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 16 (19-20) , 843-847
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Ethical and Social Issues in Pharmacogenomics TestingCurrent Pharmaceutical Design, 2010
- Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered OrganismsJournal of Law, Medicine & Ethics, 2009
- Gene Therapy Oversight: Lessons for NanobiotechnologyJournal of Law, Medicine & Ethics, 2009
- Eu Policies in Personalized Medicine-Related TechnologiesPersonalized Medicine, 2008
- Provision and quality assurance of preimplantation genetic diagnosis in EuropeEuropean Journal of Human Genetics, 2007
- Putting pharmacogenetics into practiceNature Biotechnology, 2006
- Gene therapy bio-safety: scientific and regulatory issuesGene Therapy, 2005
- Towards quality assurance and harmonization of genetic testing services in the European UnionNature Biotechnology, 2004
- European performance evaluations of the ADVIA Centaur® infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnosticsJournal of Clinical Virology, 2004
- The future of gene therapyNature, 2004